Skip to main content
. 2022 Jan 26;28(5):616–622. doi: 10.1016/j.jiac.2022.01.008

Fig. 1.

Fig. 1

Fig. 1

Box-and-whisker plots showing antimicrobial use density (AUD) and days of therapy (DOT) in fiscal years 2015–2019 and 2020. (a) Comparison of AUD/DOT between fiscal years 2015–2019 and 2020 in the emergency department and departments other than the emergency department; CEZ, CMZ, CTRX, CFPM, and ABPC/SBT. (b) Comparison of AUD/DOT between fiscal years 2015–2019 and 2020 in the emergency department and departments other than the emergency department; PIPC/TAZ, MEPM, LVFX, VCM, and TEIC. ABPC/SBT, ampicillin/sulbactam; AUD, antimicrobial use density; CAZ, ceftazidime; CEZ, cefazolin; CFPM, cefepime; CMZ, cefmetazole; CTRX, ceftriaxone; LVFX, levofloxacin; MEPM, meropenem; PIPC/TAZ, piperacillin/tazobactam; TEIC, teicoplanin; VCM, vancomycin.